164 related articles for article (PubMed ID: 23355530)
1. In vitro induction of protein complexes between bevacizumab, VEGF-A¹⁶⁵ and heparin: explanation for deposits observed on endothelial veins in monkey eyes.
Julien S; Biesemeier A; Schraermeyer U
Br J Ophthalmol; 2013 Apr; 97(4):511-7. PubMed ID: 23355530
[TBL] [Abstract][Full Text] [Related]
2. Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes.
Schraermeyer U; Julien S
Expert Opin Biol Ther; 2013 Feb; 13(2):157-67. PubMed ID: 23190450
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.
Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L; Rehak M
Ophthalmic Res; 2012; 47(3):157-62. PubMed ID: 22116547
[TBL] [Abstract][Full Text] [Related]
4. Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes.
Julien S; Biesemeier A; Taubitz T; Schraermeyer U
Br J Ophthalmol; 2014 Jun; 98(6):813-25. PubMed ID: 24457369
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-VEGF antibody on retinal ganglion cells in rats.
Iriyama A; Chen YN; Tamaki Y; Yanagi Y
Br J Ophthalmol; 2007 Sep; 91(9):1230-3. PubMed ID: 17475701
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
7. Effects of apelin and vascular endothelial growth factor on central retinal vein occlusion in monkey eyes intravitreally injected with bevacizumab: a preliminary study.
Zhao T; Lu Q; Tao Y; Liang XY; Wang K; Jiang YR
Mol Vis; 2011 Apr; 17():1044-55. PubMed ID: 21552499
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
Matsuyama K; Ogata N; Matsuoka M; Wada M; Nishimura T; Takahashi K
J Ocul Pharmacol Ther; 2011 Aug; 27(4):379-83. PubMed ID: 21810018
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.
Miyake T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ogasawara K; Ohji M
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1606-8. PubMed ID: 19875666
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys.
Kakinoki M; Sawada O; Sawada T; Saishin Y; Kawamura H; Ohji M
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5877-80. PubMed ID: 22836776
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion.
Julien S; Heiduschka P; Hofmeister S; Schraermeyer U
Br J Ophthalmol; 2008 Oct; 92(10):1424-8. PubMed ID: 18815425
[TBL] [Abstract][Full Text] [Related]
12. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.
Peters S; Heiduschka P; Julien S; Ziemssen F; Fietz H; Bartz-Schmidt KU; ; Schraermeyer U
Am J Ophthalmol; 2007 Jun; 143(6):995-1002. PubMed ID: 17449002
[TBL] [Abstract][Full Text] [Related]
14. Penetration of bevacizumab through the retina after intravitreal injection in the monkey.
Heiduschka P; Fietz H; Hofmeister S; Schultheiss S; Mack AF; Peters S; Ziemssen F; Niggemann B; Julien S; Bartz-Schmidt KU; Schraermeyer U;
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2814-23. PubMed ID: 17525217
[TBL] [Abstract][Full Text] [Related]
15. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
Kubota T; Morita H; Tou N; Nitta N; Tawara A; Satoh H; Shimajiri S
Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
[TBL] [Abstract][Full Text] [Related]
16. Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage.
Thaler S; Fiedorowicz M; Choragiewicz TJ; Bolz S; Tura A; Henke-Fahle S; Yoeruek E; Zrenner E; Bartz-Schmidt KU; Ziemssen F; Schuettauf F
Acta Ophthalmol; 2010 Aug; 88(5):e170-6. PubMed ID: 20491691
[TBL] [Abstract][Full Text] [Related]
17. Modulation of bevacizumab-induced toxicity for cultured human corneal fibroblasts.
Kim EK; Kang SW; Kim JY; Min K; Kim TI
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3922-31. PubMed ID: 23640039
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.
Heiduschka P; Julien S; Hofmeister S; Bartz-Schmidt KU; Schraermeyer U
Retina; 2008 Jan; 28(1):46-55. PubMed ID: 18185137
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
[TBL] [Abstract][Full Text] [Related]
20. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
